Many studies have indicated that increased PD-1+CD8+ T cell levels are associated with poorer prognosis in solid tumors9–12, including liver, pancreatic, head and neck cancer (HNC), non-small cell lung cancer, and early breast cancer. This evidence concerns the gene PDCD1 and breast cancer.